Our Solutions

newsletter

NEWSLETTER

  • Newsletter

    November 2015

    Nov 4, 2015

    We are pleased to announce that Algorithme Pharma is one of 19 organizations recognized at the 31st Annual Canada Awards for Excellence ceremonies on October 29 for outstanding performance. This Canadian award is equivalent to the Malcolm Baldrige National Quality Award.

    We are pleased to announce that Algorithme Pharma is one of 19 organizations recognized at the 31st Annual Canada Awards for Excellence ceremonies on October 29 for outstanding performance. This Canadian award is equivalent to the Malcolm Baldrige Nationa

  • Newsletter

    October 2015

    Oct 1, 2015

    Find out more about the fun and educational activities we have planned for you at the AAPS in Orlando, plus info on our Impaired Renal Function presentation and much more …

    Find out more about the fun and educational activities we have planned for you at the AAPS in Orlando, plus info on our Impaired Renal Function presentation and much more

  • Newsletter

    September 2015

    Sep 1, 2015

    Test your driving performance! In association with Cognitive Research Corporation (CRC), a global leader in assessing drug-impaired driving, we design and execute studies to conduct FDA‑required evaluations of the effects of drugs on the ability to operate a motor vehicle.

    Test your driving performance! In association with Cognitive Research Corporation (CRC), a global leader in assessing drug-impaired driving, we design and execute studies to conduct FDA‑required evaluations of the effects of drugs on the ability to operat

  • Newsletter

    June 2015

    Jun 1, 2015

    We provide top tier clinical trial services custom-tailored to your Therapeutic project needs. A carefully managed participant database, and local strategic partnerships with healthcare specialists, ensure ongoing access to patient populations, avoiding study-start delays or panel size restrictions.

    We provide top tier clinical trial services custom-tailored to your Therapeutic project needs. A carefully managed participant database, and local strategic partnerships with healthcare specialists, ensure ongoing access to patient populations, avoiding s

  • Newsletter

    May 2015

    May 1, 2015

    We are proud to have partnered with Cognitive Research Corporation to evaluate the sedation-related safety of Flibanserin in premenopausal women. A research study sponsored by Sprout Pharmaceuticals.

    We are proud to have partnered with Cognitive Research Corporation to evaluate the sedation-related safety of Flibanserin in premenopausal women. A research study sponsored by Sprout Pharmaceuticals.

  • Newsletter

    April 2015

    Apr 1, 2015

    We now have the ability to play a key role in the evolution of CDISC standards. As a CDISC Gold member Algorithme Phama can further collaborate with global leaders and contribute toward the development and release of new standards.

    We now have the ability to play a key role in the evolution of CDISC standards. As a CDISC Gold member Algorithme Phama can further collaborate with global leaders and contribute toward the development and release of new standards.

  • Newsletter

    February 2015

    Feb 1, 2015

    Last October, Altasciences expanded into the United States with the opening of Algorithme Pharma USA, in Fargo, North Dakota. Today, we are pleased to announce that our first studies were initiated and completed in January, just 91 days from the US contract being signed, and despite the holiday hustle.

    Last October, Altasciences expanded into the United States with the opening of Algorithme Pharma USA, in Fargo, North Dakota. Today, we are pleased to announce that our first studies were initiated and completed in January, just 91 days from the US contra

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.